long QT syndrome

This Week in PNAS

In PNAS this week: sequencing approaches to characterize cisplatin-mediated DNA damage, somatic mosaicism in long-QT syndrome case, and more.

The study, focused on two genes associated with cardiac disorders, found that patient phenotypes did not correlate with the presence or absence of a pathogenic variant.

By analyzing tweets, Canadian researchers examine the public's view of gene patenting.

NEW YORK (GenomeWeb) – A recently launched lawsuit in Canada challenging the practice of patenting genomic DNA is also asking the Federal Court to determine that advanced diagnostics utilizing next-generation sequencing platforms do not infringe patents on older testing methods involving the ampl

This article has been updated with the name of the US laboratory that sent Ontario's Ministry of Health a cease and desist letter.
NEW YORK (GenomeWeb) – The Children's Hospital of Eastern Ontario is challenging the legality of US gene patents in Canada.

NEW YORK (GenomeWeb News) – InformedDNA today said that it is providing genetic counseling to certain members of health plan Cigna.

ChanTest will develop non-clinical assays, databases, and computational models for assessing the risk of serious cardiac events associated with drug-induced QT prolongation.

The Canada Foundation for Innovation will support various university research and lab enhancement projects.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.